Cathie Wood, the renowned investor and founder of ARK Invest, recently made some notable trades. Wood’s ARK Invest bought shares of Tempus AI, a company focused on data-driven precision medicine. At the same time, ARK Invest sold off its holdings in Teladoc, a telemedicine company. Wood’s decision to invest in Tempus AI reflects her belief in the potential of data-driven healthcare solutions. Teladoc, on the other hand, saw a decrease in ARK Invest’s confidence, leading to the decision to sell off its stock. Wood’s strategic moves in the market continue to draw attention from investors and analysts alike.